Profiles for generic drugs starting with 'v'
✉ Email this page to a colleague
US Patents and Regulatory Information for v
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | TYZAVAN | vancomycin hydrochloride | SOLUTION;INTRAVENOUS | 211962-004 | Feb 15, 2019 | RX | Yes | Yes | 10,039,804 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Catalyst Pharms | AGAMREE | vamorolone | SUSPENSION;ORAL | 215239-001 | Oct 26, 2023 | RX | Yes | Yes | 11,833,159 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Deciphera Pharms | ROMVIMZA | vimseltinib | CAPSULE;ORAL | 219304-003 | Feb 14, 2025 | RX | Yes | Yes | 9,181,223 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| Amneal | VERAPAMIL HYDROCHLORIDE | verapamil hydrochloride | SOLUTION;INTRAVENOUS | 210994-001 | Jul 13, 2018 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
